First published 9/29/2026, 11:45:15 AM · Last updated 9/29/2026, 11:45:15 AM

Efficacy, Systemic Safety, and Laboratory Outcomes of Low-Dose Atropine for the Prevention of Myopia Progression in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Primary Studies

A journal article published 2026-09-04 reports a systematic review and meta-analysis evaluating low-dose atropine to prevent myopia progression in children. The publisher is listed as PT. Sanskara Karya Internasional and the content type is a journal article.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 2/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 4/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The study evaluates efficacy and systemic safety of a preventive treatment for childhood myopia, a topic relevant to pediatric eye care.

Sources

Efficacy, Systemic Safety, and Laboratory Outcomes of Low-Dose Atropine for the Prevention of Myopia Progression in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Primary Studies

Report an issue